Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

JAGX Jaguar Health, Inc.
$0.50 -8.88% -0.05
Notify me if price changes either direction
Interactive Brokers Logotype

Buy JAGX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 5.6M
Enterprise value 31.5M
Trailing PE 0.04423128
Forward PE -0.08855634
PEG Ratio -0.00058140766149224
Enterprise to EBITDA -1.018
Enterprise to revenue 2.67
Price to book MRQ 0.5903756
Price to sales TTM 0.4788286

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 11.8M
EBITDA -30909000
Diluted EPS TTM -2.58
Total Cash (MRQ) 3.5M
Current ratio (MRQ) 0.814
Operating Cash Flow (TTM) -26024000

JAGX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent JAGX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.